Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-11

FDA Approved: ELETRIPTAN HYDROBROMIDE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Eletriptan hydrobromide as an original application, authorizing a generic version of eletriptan for the acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eletriptan Hydrobromide (eletriptan hydrobromide)

Snippet

ORIG AP for ELETRIPTAN HYDROBROMIDE (ELETRIPTAN HYDROBROMIDE)